Afh. Stalenhoef et al., DECREASED RESISTANCE AGAINST IN-VITRO OXIDATION OF LDL FROM PATIENTS WITH FAMILIAL DEFECTIVE APOLIPOPROTEIN B-100, Arteriosclerosis and thrombosis, 14(3), 1994, pp. 489-493
Familial defective apolipoprotein B-100 (FDB) is caused by a mutation
in the receptor-binding region of apolipoprotein B-100, the structural
protein of the low-density lipoprotein (LDL) particle. We studied the
effect of this mutation on the composition and susceptibility to oxid
ative modification of LDL in patients with FDB. Twenty Dutch carriers
of the mutation identified in a family study were matched with 20 unaf
fected siblings of similar age and sex. The mean concentration of LDL
cholesterol was 5.19+/-0.94 versus 2.9+/-0.5 mmol/L in control subject
s (P<.0001). Measurement of LDL oxidizability in vitro by continuously
monitoring conjugated-diene absorbance showed that LDL from FDB patie
nts was significantly less resistant against oxidation (lag time, 90+/
-22 minutes versus 108+/-21 minutes; P<.05); furthermore, the maximal
rate of diene production and total diene production were also signific
antly increased. Analysis of the chemical composition revealed an incr
eased relative content of cholesteryl esters and reduced content of pr
otein in the LDL of FDB patients (cholesterol-to-protein ratio, 1.54+/
-0.24 versus 1.25+/-0.23; P<.01). The relative amount of arachidonic a
cid in LDL was increased and that of stearic acid was decreased. The v
itamin E (alpha-tocopherol) content per gram of LDL protein was simila
r to that in control subjects. The relative amount of cholesteryl este
rs and protein in LDL as well as the fatty acid composition were signi
ficantly correlated with LDL oxidizability. Thus, compositional factor
s in LDL resulting in increased susceptibility to oxidative modificati
on may contribute to the increased risk of premature vascular disease
in FDB. (Arterioscler Thromb. 1993;14:489-493.)